Royal Bank of Canada’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-240
| Closed | – | – | 7136 |
|
|
2024
Q2 | $0 | Sell |
240
-560
| -70% | – | ﹤0.01% | 7156 |
|
|
2024
Q1 | $0 | Hold |
800
| – | – | ﹤0.01% | 7107 |
|
|
2023
Q4 | $0 | Sell |
800
-460
| -37% | – | ﹤0.01% | 7084 |
|
|
2023
Q3 | $0 | Hold |
1,260
| – | – | ﹤0.01% | 7128 |
|
|
2023
Q2 | $0 | Hold |
1,260
| – | – | ﹤0.01% | 7209 |
|
|
2023
Q1 | $0 | Buy |
1,260
+600
| +91% | – | ﹤0.01% | 7034 |
|
|
2022
Q4 | $0 | Hold |
660
| – | – | ﹤0.01% | 7285 |
|
|
2022
Q3 | $0 | Hold |
660
| – | – | ﹤0.01% | 7407 |
|
|
2022
Q2 | $0 | Hold |
660
| – | – | ﹤0.01% | 7237 |
|
|
2022
Q1 | $1K | Hold |
660
| – | – | ﹤0.01% | 7146 |
|
|
2021
Q4 | $1K | Hold |
660
| – | – | ﹤0.01% | 7023 |
|
|
2021
Q3 | $2K | Buy |
+660
| New | +$2K | ﹤0.01% | 6849 |
|